# Scilex Holding Co: filings

SCLX · Nasdaq · CIK 1820190 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sclx.md) · [Financials](/companies/sclx/financials.md) · [Filings](/companies/sclx/filings.md) · [Insiders](/companies/sclx/insiders.md)

## Reports and events: 215 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (424B3 248, 8-K 144, 4 66, CORRESP 27, 425 26, EFFECT 23, 3 20, UPLOAD 19, 10-Q 17, POS AM 11, S-1/A 10, S-1 9, S-4/A 8, DEF 14A 7, S-8 7, SC 13D/A 7, 10-K 6, 424B5 6, SC 13G 6, SC 13G/A 5, SCHEDULE 13D/A 5, ARS 4, DEFA14A 4, NT 10-Q 4, S-3 4, 8-K/A 3, PRE 14A 3, SC 13D 3, SEC STAFF LETTER 3, 10-Q/A 2, D 2, DRS 2, RW 2, 10-K/A 1, 25-NSE 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, NT 10-K 1, PRER14A 1, S-1MEF 1, S-3/A 1, S-4 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 16:07 ET | [8-K](/filings/0001193125-26-407333.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-407333 |
| 2026-08-14 | 16:41 ET | [10-Q](/filings/0001193125-26-352464.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352464 |
| 2026-08-12 | 17:18 ET | [8-K](/filings/0001193125-26-347186.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-347186 |
| 2026-07-22 | 17:30 ET | [8-K](/filings/0001193125-26-312591.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-312591 |
| 2026-07-07 | 21:26 ET | [SCHEDULE 13D/A](/filings/0001193125-26-297859.md) | Ownership report, active investor, amended | 0001193125-26-297859 |
| 2026-07-06 | 06:15 ET | [8-K](/filings/0001193125-26-295493.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-295493 |
| 2026-06-29 | 17:01 ET | [8-K](/filings/0001193125-26-288677.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001193125-26-288677 |
| 2026-06-26 | 16:24 ET | [SCHEDULE 13D/A](/filings/0001193125-26-285542.md) | Ownership report, active investor, amended | 0001193125-26-285542 |
| 2026-06-24 | 16:52 ET | [8-K](/filings/0001193125-26-281213.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-281213 |
| 2026-05-20 | 17:22 ET | [10-Q](/filings/0001193125-26-232857.md) | Quarterly report, period 2026-03-31 | 0001193125-26-232857 |
| 2026-05-11 | 16:32 ET | [8-K](/filings/0001193125-26-216921.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216921 |
| 2026-05-05 | 13:24 ET | [8-K](/filings/0001193125-26-205839.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205839 |
| 2026-04-30 | 16:55 ET | [DEF 14A](/filings/0001193125-26-197717.md) | Proxy statement, period 2026-06-24 | 0001193125-26-197717 |
| 2026-04-28 | 16:58 ET | [8-K](/filings/0001193125-26-187620.md) | 1.01 Entry into a material agreement | 0001193125-26-187620 |
| 2026-04-10 | 17:29 ET | [10-K](/filings/0001193125-26-151455.md) | Annual report, period 2025-12-31 | 0001193125-26-151455 |
| 2026-03-13 | 12:59 ET | [8-K](/filings/0001193125-26-105675.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-105675 |
| 2026-03-13 | 06:03 ET | [8-K](/filings/0001193125-26-104940.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-104940 |
| 2026-02-20 | 16:14 ET | [8-K](/filings/0001193125-26-061371.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-061371 |
| 2026-02-03 | 17:03 ET | [8-K](/filings/0001193125-26-035833.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-035833 |
| 2026-02-02 | 16:07 ET | [8-K](/filings/0001193125-26-033620.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-033620 |
| 2025-12-30 | 15:37 ET | [8-K](/filings/0001193125-25-336947.md) | 7.01 Regulation FD disclosure | 0001193125-25-336947 |
| 2025-12-22 | 15:55 ET | [8-K](/filings/0001193125-25-328656.md) | 7.01 Regulation FD disclosure | 0001193125-25-328656 |
| 2025-12-17 | 10:28 ET | [8-K](/filings/0001193125-25-321928.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-321928 |
| 2025-12-16 | 21:39 ET | [S-1](/filings/0001193125-25-319720.md) | Registration statement | 0001193125-25-319720 |
| 2025-12-12 | 16:16 ET | [8-K](/filings/0001193125-25-317587.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-317587 |
| 2025-12-11 | 17:27 ET | [8-K](/filings/0001193125-25-316239.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-316239 |
| 2025-12-05 | 16:17 ET | [8-K](/filings/0001193125-25-309695.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-309695 |
| 2025-12-01 | 06:15 ET | [8-K](/filings/0001193125-25-303037.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-303037 |
| 2025-11-24 | 17:15 ET | [8-K](/filings/0001193125-25-293861.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-293861 |
| 2025-11-14 | 16:33 ET | [10-Q](/filings/0001193125-25-283153.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283153 |
| 2025-11-07 | 16:05 ET | [DEF 14A](/filings/0001193125-25-272322.md) | Proxy statement, period 2025-12-11 | 0001193125-25-272322 |
| 2025-11-04 | 13:21 ET | [8-K](/filings/0001193125-25-264143.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264143 |
| 2025-10-31 | 08:56 ET | [8-K](/filings/0001193125-25-259819.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-259819 |
| 2025-10-14 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001193125-25-238981.md) | Ownership report, active investor, amended | 0001193125-25-238981 |
| 2025-10-07 | 16:05 ET | [8-K](/filings/0001193125-25-233450.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-233450 |
| 2025-10-01 | 17:14 ET | [8-K](/filings/0001193125-25-226992.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-226992 |
| 2025-09-26 | 16:10 ET | [8-K](/filings/0001193125-25-220481.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-220481 |
| 2025-09-26 | 16:10 ET | [SCHEDULE 13D](/filings/0001193125-25-220480.md) | Ownership report, active investor | 0001193125-25-220480 |
| 2025-09-26 | 16:05 ET | [8-K](/filings/0001193125-25-220446.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-220446 |
| 2025-09-26 | 16:02 ET | [8-K](/filings/0001193125-25-220435.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-220435 |
| 2025-08-21 | 07:00 ET | [8-K](/filings/0001193125-25-184619.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-184619 |
| 2025-08-13 | 16:09 ET | [10-Q](/filings/0000950170-25-108029.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108029 |
| 2025-08-04 | 17:15 ET | [S-1](/filings/0001193125-25-172703.md) | Registration statement | 0001193125-25-172703 |
| 2025-07-23 | 08:15 ET | [8-K](/filings/0001193125-25-162969.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-162969 |
| 2025-07-23 | 08:00 ET | [8-K](/filings/0001193125-25-162938.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-162938 |
| 2025-06-23 | 17:01 ET | [8-K](/filings/0000950170-25-089059.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-089059 |
| 2025-06-23 | 16:06 ET | [8-K](/filings/0000950170-25-088971.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088971 |
| 2025-06-04 | 16:15 ET | [8-K](/filings/0000950170-25-081638.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081638 |
| 2025-05-16 | 17:17 ET | [DEF 14A](/filings/0000950170-25-073612.md) | Proxy statement, period 2025-06-04 | 0000950170-25-073612 |
| 2025-05-14 | 16:33 ET | [10-Q](/filings/0000950170-25-071517.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071517 |

Page 1 of 5. [Older](/companies/sclx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.